微浸润性导管原位癌的前哨淋巴结活检研究
该研究分析了1998至2010年间在欧洲肿瘤研究所因浸润性乳腺癌手术的微浸润性导管原位癌(DCIS)患者,纳入接受前哨淋巴结活检(SLNB)者。中位随访11年,未行腋窝淋巴结清扫的15例阳性患者仅1例区域首发事件,行清扫的16例无区域首发事件。结论认为微浸润性DCIS阳性SLN患者无病生存和总生存良好,SLNB可能并无必要。
要点
- SLN阳性未行腋窝清扫者中位随访11年区域复发风险低。
- 研究支持微浸润性DCIS可减少手术,生存不受影响。
核心结论
- 微浸润性DCIS伴前哨淋巴结阳性的患者无病生存和总生存良好。
- 微浸润性DCIS的SLNB可能并无必要,减少手术可提供同等总生存且生活质量更佳。
研究设计与样本
- 回顾性数据库分析,纳入1998至2010年欧洲肿瘤研究所因浸润性乳腺癌手术的微浸润性DCIS女性。
- 纳入接受前哨淋巴结活检者257例,中位随访11年。
主要发现
- 31例SLN阳性中16例行腋窝淋巴结清扫。
- 中位随访11年,未行腋窝清扫的15例SLN阳性患者中仅1例区域首发事件,行清扫的16例无区域首发事件。
临床怎么用
- 微浸润性DCIS患者可考虑省略前哨淋巴结活检。
- 对SLN阳性的微浸润性DCIS患者,腋窝淋巴结清扫可能可避免。
局限性
- 回顾性单中心数据库分析,样本量有限。
- SLN阳性未行腋窝清扫者仅15例,事件数少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Microinvasive breast cancer is an uncommon pathological entity. Owing to the rarity of this condition, its surgical axillary management and overall prognosis remain controversial. METHODS: A database was analysed to identify patients with microinvasive ductal carcinoma in situ (DCIS) who had surgery for invasive breast cancer at the European Institute of Oncology, Milan, between 1998 and 2010. Women who had undergone axillary staging by sentinel lymph node biopsy were included in the study. RESULTS: Of 257 women with microinvasive breast cancer who underwent sentinel lymph node biopsy (SLNB), 226 (87·9 per cent) had negative sentinel lymph nodes (SLNs) and 31 had metastatic SLNs. Twelve patients had isolated tumour cells (ITCs), 14 had micrometastases and five had macrometastases in sentinel nodes. Axillary lymph node dissection was performed in 16 of the 31 patients with positive SLNs. After a median follow-up of 11 years, only one regional first event was observed in the 15 patients with positive SLNs who did not undergo axillary lymph node dissection. There were no regional first events in the 16 patients with positive SLNs who had axillary dissection. CONCLUSION: Good disease-free and overall survival were found in women with positive SLNs and microinvasive DCIS. This study is in line with studies showing that SLNB in microinvasive DCIS may not be useful, and supports the evidence that less surgery can provide the same level of overall survival with better quality of life.
引用
- Magnoni F, Massari G, Santomauro G, et al. Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ. Br J Surg. 2019. PMID: 30791092. doi:10.1002/bjs.11079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。